Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01544731
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
LS2 | N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO- 8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE | A | 1KE6 | 0.73 |  |
DT8 | N-((1R,2S,5S)-2-(5-CHLORO-1H-INDOLE- 2-CARBOXAMIDO)-5-(DIMETHYLCARBAMOYL)CYCLOHEXYL)- 5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4- C]PYRIDINE-2-CARBOXAMIDE | A | 2EI8 | 0.75 | |
D93 | N-((1R,2R)-2-(5-CHLORO-1H-INDOLE- 2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL- 4,5,6,7-TETRAHYDROTHIAZOLO[5,4- C]PYRIDINE-2-CARBOXAMIDE | A | 2EI7 | 0.75 | |
165 | N-(BENZYLSULFONYL)-3-CYCLOHEXYLALANYL- N-(2-AMINO-1,3-BENZOTHIAZOL-6-YL)PROLINAMIDE | H,I | 1SB1 | 0.82 | |
SRS | 4-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.0(13,18)]NONADECA- 12(19),13(18),15,17-TETRAENE-10- CARBAMOYL)PENTA-METHYLSULFONEDIIMINE | A | 1MMR | 0.73 | |
RWJ | CYCLOPENTANECARBOXYLIC ACID [1- (BENZOTHIAZOLE-2-CARBONYL)-4-GUANIDINO- BUTYL]-AMIDE | A | 1QCP | 0.84 | |
D92 | N-((1R,2S)-2-(5-CHLORO-1H-INDOLE- 2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL- 4,5,6,7-TETRAHYDROTHIAZOLO[5,4- C]PYRIDINE-2-CARBOXAMIDE | A | 2EI6 | 0.75 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDI | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDX | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUX | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1MAR | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DV0 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDM | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDB | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PD5 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ9 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUZ | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDF | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVO | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVN | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ8 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HV5 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1FRB | 0.71 | |
ABB | (2S,4R)-1-ACETYL-N-[(1S)-4-[(AMINOIMINOMETHYL)AMINO]- 1-(2-BENZOTHIAZOLYLCARBONYL)BUTYL]- 4-HYDROXY-2-PYRROLIDINECARBOXAMIDE | A | 1NC6 | 0.78 | |
PR2 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2- OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN- 2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE | A | 1F0S | 0.7 | |
LS4 | 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL- 3-YLIDENE)METHYL]AMINO}-N-(1,3- THIAZOL-2-YL)BENZENESULFONAMIDE | A | 1KE8 | 0.7 | |
F32 | (5S)-5-{4-[(2S)-2-(1H-BENZIMIDAZOL- 2-YL)-2-(1,3-BENZOTHIAZOL-2-YLAMINO)ETHYL]PHENYL}ISOTHIAZOLIDIN- 3-ONE 1,1-DIOXIDE | A | 2CNF | 0.74 | |
MZ7 | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.74 | |
47D | {3-[(5-CHLORO-1,3-BENZOTHIAZOL- 2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL}ACETIC ACID | A | 2PDH | 0.74 | |
| 47D | {3-[(5-CHLORO-1,3-BENZOTHIAZOL- 2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL}ACETIC ACID | A | 2PDN | 0.74 | |
| 47D | {3-[(5-CHLORO-1,3-BENZOTHIAZOL- 2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL}ACETIC ACID | A | 2PDG | 0.74 | |
| 47D | {3-[(5-CHLORO-1,3-BENZOTHIAZOL- 2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL}ACETIC ACID | A | 2PDQ | 0.74 | |
3NA | {3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL- 2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID | A | 1Z3N | 0.71 | |
815 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1- (1-AMINO-ISOQUINOLIN-7-YLMETHYL)- 2-OXO-PYRROLDIN-3-YL]-AMIDE | A | 1F0R | 0.7 | |
K88 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7- TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)- 2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | A,D | 2WEL | 0.71 | |
MZ5 | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.71 | |
OIS | (S)-N-((2S,3R)-3-HYDROXY-4-(4-((E)- (HYDROXYIMINO)METHYL)-N-ISOBUTYLPHENYLSULFONAMIDO)- 1-PHENYLBUTAN-2-YL)-3-METHYL-2- (3-((2-METHYLTHIAZOL-4-YL)METHYL)- 2-OXOIMIDAZOLIDIN-1-YL)BUTANAMIDE | A | 1YT9 | 0.7 | |
737 | N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)- BUTYL]-2-{6-OXO-5-[(QUINOLIN-8- YLMETHYL)-AMINO]-2-M-TOLYL-6H-PYRIMIDIN- 1-YL}-ACETAMIDE | A | 1ZTL | 0.71 | |
B18 | (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)- 1,3-THIAZOL-2-YL]-4-METHYL-1-OXO- 2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE- 6-CARBOXAMIDE | A,B,C | 2PZY | 0.78 | |
D42 | 1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)- 4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL- 5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA | A | 2B52 | 0.7 | |